Linezolid for the treatment of serious gram-positive infections.
McAuley
L
L
Canadian Coordinating Office for Health Technology Assessment.
D000081:Acetamides / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D000890:Anti-Infective Agents / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use; D002170:Canada; D024881:Drug Resistance, Bacterial; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy* / Q000191:economics; D006801:Humans; D023303:Oxazolidinones / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D013673:Technology Assessment, Biomedical; D014481:United States
D000081:Acetamides; D000890:Anti-Infective Agents; D023303:Oxazolidinones